Public Profile

Asia Drug and Chemical

Asia Drug and Chemical Co., Ltd., commonly referred to as Asia Drug, is a prominent player in the pharmaceutical and chemical industry, headquartered in Thailand. Established in 1992, the company has made significant strides in the production and distribution of high-quality pharmaceutical products and active pharmaceutical ingredients (APIs) across Southeast Asia. With a strong focus on research and development, Asia Drug offers a diverse range of products, including generic medications and specialty chemicals, which are distinguished by their adherence to stringent quality standards. The company has earned a reputation for innovation and reliability, positioning itself as a trusted partner in the healthcare sector. Asia Drug's commitment to excellence is reflected in its robust market presence and notable achievements, including certifications from international regulatory bodies. This dedication to quality and service has solidified its status as a leader in the region's pharmaceutical landscape.

DitchCarbon Score

How does Asia Drug and Chemical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

13

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

Asia Drug and Chemical's score of 13 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.

14%

Let us know if this data was useful to you

Asia Drug and Chemical's reported carbon emissions

Asia Drug and Chemical, headquartered in Thailand, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Asia Drug and Chemical may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, it will be essential for the company to consider developing and communicating its climate strategies to align with global standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Asia Drug and Chemical's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Asia Drug and Chemical is in TH, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Asia Drug and Chemical is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers